Structures by: Arumugam N.
Total: 52
Na3 Mo O3 N
MoNNa3O3
Zeitschrift fuer Anorganische und Allgemeine Chemie (2003) 629, 939-941
a=7.2463Å b=6.2498Å c=5.6386Å
α=90° β=90° γ=90°
C37H33N5O4
C37H33N5O4
RSC Advances (2020) 10, 40 23522-23531
a=11.5002(7)Å b=11.7543(8)Å c=14.3642(10)Å
α=97.266(5)° β=106.616(5)° γ=111.900(5)°
1-(3-Bromo-1-phenylsulfonyl-1H-indol-2-ylmethyl)-pyrrolidine-2,5-dione
C19H15BrN2O4S
Acta Crystallographica Section E (2003) 59, 12 o1903-o1906
a=11.4561(5)Å b=15.1588(7)Å c=11.6819(5)Å
α=90.00° β=116.4930(10)° γ=90.00°
3-Bromo-2-(2-bromo-4,5-dimethoxybenzyl)-1-phenylsulfonyl-1H-indole
C23H19Br2NO4S
Acta Crystallographica Section E (2005) 61, 4 o998-o1000
a=8.7855(7)Å b=9.8033(7)Å c=14.8740(10)Å
α=88.3680(10)° β=79.0650(10)° γ=64.0900(10)°
2-(3-Bromo-1-phenylsulfonyl-1H-indole-2-ylmethylsulfanyl)-6-methyl-1H- benzimidazole
C23H18BrN3O2S2
Acta Crystallographica Section E (2005) 61, 4 o1184-o1186
a=9.8818(5)Å b=24.3572(13)Å c=9.7867(5)Å
α=90.00° β=99.4200(10)° γ=90.00°
2,5-Dimethyl-7-phenylsulfonyl-5,6-dihydroindolo[2,3-c]benzazepin-12-one
C24H20N2O3S
Acta Crystallographica Section E (2005) 61, 8 o2410-o2412
a=15.6032(7)Å b=15.9227(7)Å c=16.3694(7)Å
α=90.00° β=90.00° γ=90.00°
3-Bromo-2-(4-bromo-2,5-dimethoxybenzyl)-1-phenylsulfonyl-1H-indole
C23H19Br2NO4S
Acta Crystallographica Section E (2005) 61, 8 o2455-o2457
a=33.177(2)Å b=9.0850(6)Å c=16.1712(10)Å
α=90.00° β=111.8020(10)° γ=90.00°
2-(2-Acetamido-5-methylbenzoyl)indole
C18H16N2O2
Acta Crystallographica Section E (2005) 61, 10 o3291-o3293
a=21.8765(12)Å b=14.3774(8)Å c=11.7603(7)Å
α=90.00° β=107.0500(10)° γ=90.00°
3-(4-Chlorophenyl)-4-(4-methoxyphenyl)-6-(phenylselenylmethyl)- 2,3,3a,3b,4,5,5a,6,1'',2'',3'',4''-dodecahydroazeto[2',3':3,4]pyrrolo[1,2- <i>b</i>]isoxazole-2-spiro-2''-naphthalene-5,1''-dione
C36H31ClN2O4Se
Acta Crystallographica Section E (2008) 64, 4 o716-o717
a=14.4697(3)Å b=10.9493(3)Å c=19.3011(4)Å
α=90.00° β=94.6610(10)° γ=90.00°
Methyl 3-(2-chlorophenyl)-2-(1H-indol-3-ylmethyl)-5-[1-(4-methoxyphenyl)-4-oxo- 3-phenylazetidin-2-yl]-4-nitropyrrolidine-2-carboxylate
C37H33ClN4O6
Acta Crystallographica Section E (2008) 64, 6 o1070-o1071
a=10.399(3)Å b=12.500(3)Å c=14.211(3)Å
α=93.766(6)° β=99.962(6)° γ=114.066(5)°
Methyl 2-benzyl-5-[1-(4-methoxyphenyl)-4-oxo-3-phenylazetidin-2-yl]-4-nitro-3-phenylpyrrolidine-2-carboxylate
C35H33N3O6
Acta Crystallographica Section E (2008) 64, 10 o1993
a=10.1727(2)Å b=10.4210(2)Å c=15.1680(3)Å
α=91.8330(10)° β=106.1540(10)° γ=102.5360(10)°
Ethyl-1-(4-chlorophenyl)-2-nitro-3-[4-oxo-3-phenyl-1-(4-methoxyphenyl) azetidine-2-yl]-2,3,10,10a-tetrahydro-1H, 5H-pyrrolo[1,2-b] isoquinoline-10a- carboxylate
C37H34ClN3O6
Acta Crystallographica Section E (2008) 64, 10 o2042
a=9.1723(2)Å b=18.0452(4)Å c=19.7475(5)Å
α=90.00° β=100.6380(10)° γ=90.00°
Methyl 3-(4-bromophenyl)-2-(1<i>H</i>-indol-3-ylmethyl)-5-[1-(4-methoxyphenyl)- 4-oxo-2-phenylazetidin-2-yl]-4-nitropyrrolidine-2-carboxylate
C37H33BrN4O6
Acta Crystallographica Section E (2008) 64, 6 o1095-o1096
a=11.3988(4)Å b=34.8587(13)Å c=8.7039(3)Å
α=90.00° β=100.982(2)° γ=90.00°
Ethyl 2-(1H-indol-3-yl)-5-[1-(4-methoxyphenyl)-4-oxo-3-phenylazetidin-2-yl]- 4-nitro-3-(p-tolyl)pyrrolidine-2-carboxylate
C39H38N4O6
Acta Crystallographica Section E (2007) 63, 5 o2221-o2223
a=11.2689(8)Å b=35.612(2)Å c=8.8848(6)Å
α=90.00° β=99.7850(10)° γ=90.00°
Ethyl 1-(4-methoxyphenyl)-2-nitro-3-[4-oxo-3-phenyl-1-(4-methoxyphenyl)azetidin-2-\ yl]-2,3,10,10a-tetrahydro-1H,5H-pyrrolo[1,2-b]isoquinoline-10a-carboxylate
C38H37N3O7
Acta Crystallographica Section E (2008) 64, 5 o887-o888
a=9.0149(3)Å b=11.0865(4)Å c=33.3731(11)Å
α=90.00° β=90.00° γ=90.00°
1-(4-Methoxyphenyl)-7-phenyl-3-\ (phenylselenylmethyl)perhydroisoxazolo[2,3':1,2]pyrrolo[3,4-\ <i>b</i>]azetidine-6-spiro-2'-chroman-2,4'-dione
C35H30N2O5Se
Acta Crystallographica Section E (2008) 64, 5 o851-o852
a=14.0886(5)Å b=10.6813(4)Å c=19.4744(7)Å
α=90.00° β=92.721(2)° γ=90.00°
4'-(4-Chlorophenyl)-2'-[1-(4-methoxyphenyl)-4-oxo-3-phenylazetidin- 2-yl]-1'-methyl-2-phenyl-spiro[1,3-oxazole-4(5H),3'-pyrrolidin]-5-one
C35H30ClN3O4
Acta Crystallographica Section E (2006) 62, 9 o4166-o4168
a=10.0409(10)Å b=13.2335(13)Å c=13.4951(13)Å
α=117.751(2)° β=94.976(2)° γ=98.865(2)°
Ethyl 1'-[1-(4-methoxyphenyl)-3-phenoxy-4-phenylazetidin-1-yl]-1,3-dioxo- 2',3',5',6',7',7a'-hexahydroindan-2-spiro-3'-1'H-pyrrolizine-2'-carboxylate
C34H32N2O7
Acta Crystallographica Section E (2008) 64, 9 o1832-o1833
a=12.4776(7)Å b=12.4946(6)Å c=19.4958(11)Å
α=90.00° β=106.013(3)° γ=90.00°
N-{4-Bromo-2-[(3-bromo-1-phenylsulfonyl-1H-indol-2-yl)methyl]- 5-methoxyphenyl}acetamide
C24H20Br2N2O4S
Acta Crystallographica Section C (2003) 59, 3 o137-o140
a=10.2647(11)Å b=24.976(3)Å c=9.7963(11)Å
α=90° β=104.760(2)° γ=90°
Lithium bismuth triphosphate
Bi58.94O152P24,8(Li)
Acta Crystallographica Section C (2007) 63, 10 i86-i88
a=30.796(6)Å b=5.2836(11)Å c=24.594(5)Å
α=90.00° β=122.87(3)° γ=90.00°
Hexabismuth iron tetraphosphate tetraoxide
Bi6.31Fe0.69O20P4
Acta Crystallographica Section C (2008) 64, 8 i71-i72
a=9.2097(18)Å b=7.5214(15)Å c=6.9033(14)Å
α=112.48(3)° β=93.71(3)° γ=106.95(3)°
Ethyl 1-<i>tert</i>-butyl-2-(4-hydroxy-3-methoxyphenyl)-1<i>H</i>-benzimidazole-5-carboxylate
C21H24N2O4
Acta Crystallographica Section E (2010) 66, 5 o1051-o1052
a=9.2610(6)Å b=13.6096(9)Å c=16.3200(9)Å
α=90.00° β=113.560(3)° γ=90.00°
Ethyl 1-(2-hydroxyethyl)-2-<i>p</i>-tolyl-1<i>H</i>-benzimidazole-5-carboxylate
C19H20N2O3
Acta Crystallographica Section E (2010) 66, 7 o1590-o1591
a=9.0400(9)Å b=12.6806(13)Å c=15.5504(17)Å
α=74.170(2)° β=74.360(2)° γ=76.721(2)°
C37H35N3O6
C37H35N3O6
Acta Crystallographica Section E (2010) 66, 3 o646
a=9.3039(3)Å b=13.0725(3)Å c=13.8814(3)Å
α=87.5040(10)° β=74.1230(10)° γ=74.9260(10)°
Ethyl 1-<i>tert</i>-butyl-2-(4-methoxyphenyl)-1<i>H</i>-benzimidazole-5-carboxylate
C21H24N2O3
Acta Crystallographica Section E (2010) 66, 4 o776-o777
a=14.3963(7)Å b=8.6206(5)Å c=15.1609(8)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 1-<i>sec</i>-butyl-2-phenyl-1<i>H</i>-benzimidazole-5-carboxylate
C20H22N2O2
Acta Crystallographica Section E (2010) 66, 4 o796-o797
a=9.9926(7)Å b=12.3287(11)Å c=13.9635(12)Å
α=90.00° β=93.120(3)° γ=90.00°
Ethyl 1-<i>sec</i>-butyl-2-(4-methoxyphenyl)-1<i>H</i>-benzimidazole-5-carboxylate
C21H24N2O3
Acta Crystallographica Section E (2010) 66, 4 o845
a=10.5815(3)Å b=12.1079(3)Å c=15.1050(3)Å
α=90.00° β=93.678(2)° γ=90.00°
Ethyl 1-<i>sec</i>-butyl-2-<i>p</i>-tolyl-1<i>H</i>-benzimidazole-5-carboxylate
C21H24N2O2
Acta Crystallographica Section E (2010) 66, 5 o1214-o1215
a=10.6093(7)Å b=12.5617(9)Å c=13.6025(10)Å
α=90.00° β=96.412(2)° γ=90.00°
Ethyl 1-<i>sec</i>-butyl-2-(2-hydroxyphenyl)-1<i>H</i>-benzimidazole-5-carboxylate 0.25-hydrate
C20H22N2O3,0.25(H2O)
Acta Crystallographica Section E (2010) 66, 6 o1285-o1286
a=7.0484(11)Å b=27.262(4)Å c=9.4673(14)Å
α=90.00° β=97.495(3)° γ=90.00°
Ethyl 3-amino-4-[(2-hydroxyethyl)amino]benzoate
C11H16N2O3
Acta Crystallographica Section E (2010) 66, 8 o2141
a=23.2300(5)Å b=14.5914(4)Å c=7.58150(10)Å
α=90.00° β=108.9310(10)° γ=90.00°
Ethyl 1-<i>sec</i>-butyl-2-(4-chlorophenyl)-1<i>H</i>-benzimidazole-5-carboxylate
C20H21ClN2O2
Acta Crystallographica Section E (2010) 66, 9 o2412-o2413
a=10.4321(9)Å b=12.6218(12)Å c=13.6896(12)Å
α=90.00° β=97.043(3)° γ=90.00°
Ethyl 1-<i>sec</i>-butyl-2-(4-fluorophenyl)-1<i>H</i>-benzimidazole- 5-carboxylate
C20H21FN2O2
Acta Crystallographica Section E (2011) 67, 11 o2938
a=10.2249(16)Å b=12.3767(18)Å c=14.149(2)Å
α=90.00° β=93.473(2)° γ=90.00°
Ethyl 1-(2-hydroxyethyl)-2-(4-methoxyphenyl)-1<i>H</i>-benzimidazole- 5-carboxylate monohydrate
C19H20N2O4,H2O
Acta Crystallographica Section E (2012) 68, 2 o421
a=10.6364(11)Å b=9.5089(10)Å c=19.3765(17)Å
α=90.00° β=112.899(5)° γ=90.00°
5-Fluoro-6'<i>H</i>,7'<i>H</i>,8'<i>H</i>-spiro[indoline-3,7'- pyrano[3,2-<i>c</i>:5,6-<i>c</i>']di-1-benzopyran]-2,6',8'-trione
C26H12FNO6
Acta Crystallographica Section E (2012) 68, 3 o744
a=7.82620(10)Å b=10.92780(10)Å c=12.4067(2)Å
α=113.3740(10)° β=94.9220(10)° γ=100.2950(10)°
5-Methylspiro[indoline-3,7'-[6<i>H</i>,7<i>H</i>,8<i>H</i>]pyrano[3,2- <i>c</i>:5,6-<i>c</i>']di[1]benzopyran]-2,6',8'-trione chloroform hemisolvate
C27H15NO6,0.5(CHCl3)
Acta Crystallographica Section E (2012) 68, 4 o1194
a=9.9341(2)Å b=19.1498(4)Å c=12.8279(2)Å
α=90.00° β=95.0780(10)° γ=90.00°
(3<i>E</i>,5<i>E</i>)-1-Allyl-3,5-bis(4-methoxybenzylidene)piperidin-4-one
C24H25NO3
Acta Crystallographica Section E (2013) 69, 7 o1071
a=19.2409(15)Å b=6.8457(6)Å c=15.6393(13)Å
α=90.00° β=98.255(2)° γ=90.00°
Ethyl 2-(4-bromophenyl)-1-<i>sec</i>-butyl-1<i>H</i>-benzimidazole-5-carboxylate
C20H21BrN2O2
Acta Crystallographica Section E (2011) 67, 12 o3453
a=10.5187(2)Å b=12.7525(2)Å c=13.7444(2)Å
α=90.00° β=98.1010(10)° γ=90.00°
10-(4-Methylbenzylidene)anthracen-9(10<i>H</i>)-one
C22H16O
Acta Crystallographica Section E (2012) 68, 2 o478-o479
a=7.29590(10)Å b=16.3853(2)Å c=13.0028(2)Å
α=90.00° β=90.00° γ=90.00°
(2<i>RS</i>,3<i>SR</i>,10<i>SR</i>,11<i>RS</i>)-3,10-Diphenoxy-18,21-dioxa-5,8- diazapentacyclo[20.4.0.0^2,5^.0^8,11^.0^12,17^]hexacosa- 1(26),12,14,16,22,24-hexaene-4,9-dione ethyl acetate hemisolvate
C34H30N2O6,0.5(C4H8O2)
Acta Crystallographica Section E (2011) 67, 8 o2203
a=18.037(3)Å b=17.201(3)Å c=21.589(4)Å
α=90.00° β=108.722(10)° γ=90.00°
11-Hydroxy-9-(prop-2-en-1-yl)-9,10-dihydro-9,10-propanoanthracen-12-one
C20H18O2
Acta Crystallographica Section E (2011) 67, 9 o2487
a=7.609400(10)Å b=9.160900(10)Å c=11.1735(2)Å
α=84.2020(10)° β=85.7070(10)° γ=69.8950(10)°
9-(pent-4-enyl)anthracene
C19H18
Acta Crystallographica Section E (2011) 67, 9 o2251
a=11.1555(2)Å b=7.26780(10)Å c=19.7129(3)Å
α=90.00° β=119.0960(10)° γ=90.00°
Ethyl 1-(butan-2-yl)-2-(2-methoxyphenyl)-1<i>H</i>-benzimidazole-5-carboxylate
C21H24N2O3
Acta Crystallographica Section E (2011) 67, 12 o3231-o3232
a=10.6746(3)Å b=12.3344(4)Å c=15.6158(5)Å
α=90.00° β=106.9010(10)° γ=90.00°
5-Chlorospiro[indoline-3,7'-6<i>H</i>,7<i>H</i>,8<i>H</i>-pyrano[3,2- <i>c</i>:5,6-<i>c</i>']di[1]benzopyran]-2,6',8'-trione
C26H12ClNO6
Acta Crystallographica Section E (2012) 68, 4 o1172
a=16.1910(3)Å b=12.9931(3)Å c=20.8743(4)Å
α=90.00° β=109.0910(10)° γ=90.00°
2-Hydroxy-5-[(<i>E</i>)-2-methylbenzylidene]-8-(2-methylphenyl)-9-phenyl- 3,10-diazahexacyclo[10.7.1.1^3,7^.0^2,11^.0^7,11^.0^16,20^]henicosa- 1(20),12,14,16,18-pentaen-6-one
C40H34N2O2
Acta Crystallographica Section E (2012) 68, 12 o3375
a=14.0679(2)Å b=7.72450(10)Å c=26.9686(3)Å
α=90.00° β=92.5960(10)° γ=90.00°
1''-Allyl-5''-(4-methoxybenzylidene)-7'-(4-methoxyphenyl)-1',3',5',6',7',7a'-hexahydrodispiro[acenaphthylene-1,5'-pyrrolo[1,2-<i>c</i>][1,3]thiazole-6',3''-piperidine]-2,4''(1<i>H</i>)-dione
C39H36N2O4S
Acta Crystallographica Section E (2013) 69, 8 o1345-o1346
a=11.3956(7)Å b=20.1346(12)Å c=14.3860(8)Å
α=90.00° β=103.1530(10)° γ=90.00°
9-(2-Chlorobenzylidene)anthracen-10(9<i>H</i>)-one
C21H13ClO
Acta Crystallographica Section E (2013) 69, 5 o627
a=7.9106(10)Å b=8.3598(10)Å c=12.6906(15)Å
α=82.813(7)° β=83.979(7)° γ=67.741(6)°
Ga2GeLiS6
Ga2GeLiS6
Chemistry of Materials (2008) 20, 19 6048
a=11.943(5)Å b=22.590(8)Å c=6.805(2)Å
α=90.00° β=90.00° γ=90.00°
4'-(2,4-Dichlorophenyl)-1',3''-dimethyl-1''-phenyl-7'' ,8''-dihydrodispiro[indoline-3,2'-pyrrolidine-3', 6''-pyrazolo[3,4-b]quinoline]-2,5''(1''H)-dione
C34H27Cl2N5O2
ACS combinatorial science (2016) 18, 5 262-270
a=14.3841(9)Å b=14.7846(8)Å c=16.9692(11)Å
α=91.767(11)° β=96.391(14)° γ=92.148(12)°
3-methyl-1-phenyl-1,6,7,8-tetrahydro-5H-pyrazolo[3,4-b]quinolin-5-one
C17H15N3O
ACS combinatorial science (2016) 18, 5 262-270
a=13.6926(10)Å b=18.4002(13)Å c=22.7816(17)Å
α=90° β=99.3660(10)° γ=90°
4-(3,7,7-trimethyl-5-oxo-5,6,7,8-tetrahydro-1H- pyrazolo[3,4-b]quinolin-1-yl)benzonitrile
C20H18N4O
ACS combinatorial science (2016) 18, 5 262-270
a=8.8290(9)Å b=9.7497(10)Å c=11.1413(12)Å
α=80.054(2)° β=72.419(2)° γ=72.098(2)°
tripotassium monosodium ditungstate
K3NaO8W2
Zeitschrift für Kristallographie - New Crystal Structures (2005) 220, 4 531-532
a=10.4928(1)Å b=6.0693(1)Å c=15.2921(1)Å
α=90° β=90.087(2)° γ=90°
C24H20ClNO2
C24H20ClNO2
Organic & biomolecular chemistry (2021)
a=12.2034(4)Å b=8.3948(3)Å c=19.2731(6)Å
α=90.00° β=91.400(3)° γ=90.00°